Related Experiment Videos

Outcomes after judicious antibiotic use for respiratory tract infections seen in a private pediatric practice

M E Pichichero1, J L Green, A B Francis

  • 1Elmwood Pediatric Group, Department of Microbiology/Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA. mepo@uhura.cc.rochester.edu

Pediatrics
|April 1, 2000
PubMed

Insights

In children with respiratory tract infections (RTIs), antibiotics are often unnecessary. Judicious antibiotic use in pediatric practice did not increase return visits or subsequent bacterial infections.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Most childhood respiratory tract infections (RTIs) are viral and self-limiting, often not requiring antibiotic treatment.
  • Antibiotic overuse contributes to resistance and adverse effects, necessitating judicious prescribing practices.

Purpose of the Study:

  • To evaluate the safety and efficacy of judicious antibiotic use in pediatric private practice for RTIs.
  • To determine if withholding antibiotics for viral RTIs increases return office visits or secondary bacterial infections.

Main Methods:

  • Prospective 12-month study involving children with acute respiratory tract illness.
  • Viral cultures performed on all patients; follow-up for 30 days to assess outcomes.
  • Antibiotics prescribed only for presumed or documented bacterial infections.

Main Results:

  • Out of 383 children, 77% did not receive antibiotics initially.
  • Children not receiving antibiotics had similar rates of unscheduled return visits (29%) compared to those who did (44%).
  • No increase in bacterial infections was observed in children managed without antibiotics.

Conclusions:

  • Children with RTIs lacking evidence of bacterial infection do not require antibiotics.
  • Judicious antibiotic stewardship in pediatric practice is effective and safe for managing RTIs.
  • This approach reduces unnecessary antibiotic exposure without compromising patient outcomes.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...